Cargando…
Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin
PP2A is a master controller of multiple inflammatory signaling pathways. It is a target in asthma; however the molecular mechanisms by which PP2A controls inflammation warrant further investigation. In A549 lung epithelial cells in vitro we show that inhibition of basal PP2A activity by okadaic acid...
Autores principales: | Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434956/ https://www.ncbi.nlm.nih.gov/pubmed/25985190 http://dx.doi.org/10.1038/srep10063 |
Ejemplares similares
-
Long-Acting β(2)-Agonists Increase Fluticasone Propionate-Induced Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1) in Airway Smooth Muscle Cells
por: Manetsch, Melanie, et al.
Publicado: (2013) -
Dual-Specificity Phosphatase 1 and Tristetraprolin Cooperate To Regulate Macrophage Responses to Lipopolysaccharide
por: Smallie, Tim, et al.
Publicado: (2015) -
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
por: Nader, Cassandra P., et al.
Publicado: (2019) -
Enhancing tristetraprolin activity reduces the severity of cigarette smoke‐induced experimental chronic obstructive pulmonary disease
por: Nair, Prema M, et al.
Publicado: (2019) -
MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth
por: O’Neil, J.D., et al.
Publicado: (2018)